Orthopedic Bone Cement and Casting Materials Market

The global Orthopedic Bone Cement and Casting Materials Market is valued at USD 3.4 Billion in 2024 and is projected to reach a value of USD 6.7 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 8.8% between 2025 and 2035.

The Market is driven by advancements in casting materials & techniques, rising prevalence of orthopedic disorders & injuries, and a growing demand for minimally invasive procedures. The Orthopedic Bone Cement and Casting Materials market focuses on products for stabilizing and repairing bone fractures and joint replacements. Orthopedic bone cement is generally used to fix implants and fill gaps between bones and prosthesis during joint replacement procedures, hence promoting stability and healing.

Key Highlights

• In 2024, based on the Product, the Bone Cement category accounted for significant market share of 54.10%
• Based on the Application, the Joint Arthroplasty category accounted for significant market share of 38.40% in 2024
• In 2024, by End User, Hospitals dominated the market with significant market share of 56.20%
• North America dominated the market with 46.20% market share in 2024
• Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period

Product Overview

​

The Bone cement segment is also referred to as polymethylmethacrylate (PMMA) cement, is a key component in orthopedic surgery. It is a biocompatible chemical that is combined and injected into the bone to offer stability and support. Once injected, the cement solidifies fast and forms a strong link with the bone. Among the many advantages of bone cement are its quick fixing time, reduced discomfort, and adaptability to the individual needs of each patient.

Casting materials is growing at fastest rate during the forecast period. It plays a significant role in cripple and supporting fractured bones throughout the healing process. Commonly made from materials such as fiberglass or plaster of Paris (POP), these materials are molded into casts or splints around the injured area. . Casting material offers a lightweight, breathable, and adjustable solution that maintains proper bone alignment and immobilization. The casting material is widely used in orthopedic clinics and hospitals, they are essential for treating fractures, sprains, and various orthopedic conditions that need immobilization and support.

Application Overview

The Application segment is divided into joint arthroplasty, trauma cases, sports injury, spine surgeries, and others. The joint arthroplasty segment held the dominant share in 2024, accounting for significant market share of 38.40%.

The surgical process of replacing damaged or arthritic joints with artificial implants is known as joint arthroplasty. Because they offer stability and attachment for the prosthetic components, orthopedic bone cement and casting materials are essential in this application. By preventing joint dislocation or loosening and guaranteeing a stable implant attachment, these materials help patients restore their mobility and reduce pain.

Orthopedic bone cement and casting materials are crucial for stabilizing and immobilizing injured bones for the best possible recovery in trauma instances such as fractures and dislocations. While casting materials, like fiberglass or plaster casts, provide the required immobilization, bone cement is frequently utilized to bind fractures.

Orthopedic bone cement and casting material are frequently needed for sports-related injuries, such as sprains, fractures, and ligament tears, in order to preserve the wounded area, promote healing, and stop additional harm. Athletes can resume their sporting activities thanks to these materials' assistance in reducing swelling, relieving pain, and improving recovery.

End User Overview

The End User segment is divided into hospitals, ambulatory surgical centers, and orthopedic clinics. The Hospitals segment held the dominant share in 2024, accounting for significant market share of 56.20%.

Hospitals include well-established orthopedic departments with the resources and equipment needed to handle complicated fracture treatments and orthopedic procedures. Comprehensive orthopedic services, such as emergency care, inpatient operations, and post-operative rehabilitation, are provided by these facilities. The need for sports medicine products, such as solutions for ligament and fracture repair, in these facilities is rising due to increased access to competent specialists and an increase in admissions for trauma and sports injuries.

Ambulatory surgical centers (ASCs) are outpatient facilities offering surgical care without requiring overnight stays. They known for their cost-effectiveness, convenience, and shorter recovery periods, ASCs have grown in popularity. They commonly perform orthopedic procedures like arthroscopy, fracture reduction, and casting. Providing a streamlined and efficient setting for orthopedic treatments, ASCs have become a significant end user of orthopedic bone cement and casting materials.

Regional Overview

In 2024, the North America captured 46.20% of the revenue share

North America Orthopedic Bone Cement and Casting Materials market is driven by aging population, sedentary lifestyles, and sports-related injuries. In region, the skilled healthcare professionals, presence of advanced healthcare infrastructure, and favorable compensate policies contribute to the markets growth. Furthermore, the region is at the forefront of medical technology advancements, leading to the development and adoption of innovative orthopedic materials and procedures.

U.S. is anticipated to grow at the highest CAGR of 2.40% during the forecast period, driven by aging population, rising cases of osteoporosis and arthritis, and the increasing demand for minimally invasive orthopedic procedures. According CDC data, indicates that approximately 60 million people in the U.S. have been diagnosed with arthritis. These conditions frequently demand for medical intervention, including the use of bone cement and casting materials for fracture fixation, joint replacements, and various other orthopedic procedures.

In Europe, the market is driven by factors such as the increasing aging population, well-established healthcare systems, and rising prevalence of musculoskeletal disorders. Moreover, favorable government initiatives and reimbursement policies further drives market growth. Europe also has a strong presence of key market players, leading to a competitive and robust market landscape.

In the Asia Pacific region, the market is affected by the rapid urbanization, large population base, and increasing healthcare expenditure. Improving healthcare infrastructure, Rising awareness about orthopedic treatments, and the growing adoption of advanced medical technologies drives the market growth. Additionally, a significant number of road accidents, sports injuries, and a rising aging population in countries like China and Japan further drives the demand for Orthopedic Bone Cement and Casting Materials.

Based on the provided market data, Vantage Market Research offers customizations in the reports to meet the specific needs of clients.

Key Trends

• Increasing Popularity of Lightweight and Water-Resistant Casting Materials: Advanced materials like fiberglass and polymer-based options are becoming more popular than traditional plaster of Paris. These newer materials provide greater patient comfort, are lighter, and allow for waterproof casts, which can enhance mobility and convenience for patients during recovery
• Technological Integration for Precision and Customization: Technologies such as 3D printing and digital imaging are facilitating customized casts and splints tailored to individual patients’ anatomies, leading to improved healing and patient satisfaction. Additionally, digital monitoring of cast fit and function is emerging as a trend to enhance the quality of patient care
• Rising Sports Injuries and Trauma Cases: With the increasing participation in sports and physical activities, the incidence of fractures, ligament injuries, and other musculoskeletal trauma is rising. This trend fuels the demand for casting materials and bone cement to treat injuries and ensure proper healing

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Increasing incidence of sports-related injuries and road accidents.

In Worldwide, the increasing incidence of sports-related injuries and road accidents is a prominent driver for the Orthopedic Bone Cement and Casting Materials market. With the growing popularity of sports activities and the rise in road traffic, the incidence of fractures and musculoskeletal injuries has surged. The management of these injuries is greatly simplified by orthopedic bone cement and casting materials, which immobilize, stabilize, and support the injured bones and joints. The demand for these materials is driven by the need for quick and effective fracture fixation, enabling athletes and accident injured persons to resume their normal activities at the earliest. Additionally, the development of lightweight and durable materials has making possible to patient compliance and comfort during the healing process, thus favoring the market growth.

Rising incidence of orthopedic disorders and injuries

In Orthopedic Bone Cement and Casting Materials market growth factors such as sedentary lifestyles, obesity, and age-related conditions contribute to the growing incidence of orthopedic ailments such as fractures, osteoarthritis, and joint disorders. The utilization of bone cement and casting materials for joint replacement surgeries, efficient fracture fixation, and other orthopedic procedures is required due to the growing patient population. The need for pain treatment, increased mobility, and improved patient quality of life are what are driving demand for these materials.

Surging advancements in casting materials

The comfort and mobility of patients during the healing process are enhanced by the new casting materials' many advantages, which include being lighter, stronger, and water-resistant. These materials are also frequently more breathable, which lowers the possibility of skin irritation and improves general hygiene. The creation of castings with improved fit and support—some even enabling digital modification via 3D scanning—is another example of advancements in the formulation of these casting materials.

Competitive Landscape

The Orthopedic Bone Cement and Casting Materials market is characterized by the presence of both established players and emerging companies, each strive for market share through product innovation, strategic partnerships, and geographic expansion. Industry giants like DePuy Chemicals, 3M Healthcare Ltd., Stryker Corporation, Biomet Inc, Smith & Nephew Plc, Exactech Inc, Zimmer Holdings Inc., Orthofix International S.V., BSN Medical GmbH. These companies are heavily involved in research and development (R&D), constantly innovating to offer better-performing and more durable bone cement formulations or casting materials, often focusing on specific areas like antibiotic-loaded cements and lightweight synthetic casts. Emerging markets, especially in regions like Asia Pacific, Latin America, and the Middle East, are becoming increasingly important due to growing healthcare demands, particularly in orthopedic procedures.

The key players in the global Orthopedic Bone Cement and Casting Materials market include - DePuy Chemicals among others.

Recent Market Developments

Zimmer Biomet Signs Definitive Agreement to Acquire OrthoGrid Systems Inc.

• In August 2024, Zimmer Biomet Holdings, Inc., a global medical technology leader, today announced that it signed a definitive agreement to acquire OrthoGrid Systems, Inc., (OrthoGrid) a privately-held medical technology company focused on artificial intelligence (AI)-driven surgical guidance systems for total hip replacement. The acquisition includes OrthoGrids AI-powered, fluoroscopy-based surgical assistance platform HIP AI, as well as two additional FDA-cleared orthopedic applications and over 40 patents

DePuy Synthes Receives 510(k) FDA Clearance of the VELYS™ Robotic-Assisted Solution for Use in Unicompartmental Knee Arthroplasty Procedures

• In June 2024, Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has received 510(k) FDA clearance for the clinical application of the VELYS™ Robotic-Assisted Solution in Unicompartmental Knee Arthroplasty (UKA). The expanded indication builds upon the VELYS Robotic-Assisted Solution platform used in Total Knee Arthroplasty (TKA), which has been cleared for use in 20 markets and utilized in over 55,000 procedures, equipping surgeons with the information needed to help preserve the soft tissue envelope, predict joint stability and work toward returning knee function

The global Orthopedic Bone Cement and Casting Materials market can be categorized as Product, Application, End User and Region.